Collection of Medical Drug Information in Pharmacies: Drug Event Monitoring (DEM) in Japan-Reference-Cited by-同舟云学术

Collection of Medical Drug Information in Pharmacies: Drug Event Monitoring (DEM) in Japan

Published:2005-07-01 Issue:7 Volume:125 Page:555-565
ISSN:0031-6903
Container-title:YAKUGAKU ZASSHI
language:en
Short-container-title:YAKUGAKU ZASSHI

Author:

HAYASHI Sei-ichiro¹,NANAUMI Akira²,AKIBA Yasuji²,KOMIYAMA Takako³,TAKEUCHI Koichi⁴

Affiliation:

1. Central Pharmaceutical Information Center, The Japan Pharmaceutical Association

2. The Japan Pharmaceutical Association

3. Division of Clinical Pharmacy, Center for Clinical Pharmacy and Clinical Sciences, School of Pharmaceutical Sciences, Kitasato University

4. Department of Clinical Pharmacology, Meiji Pharmaceutical University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/yakushi/125/7/125_7_555/_pdf

Reference10 articles.

1. 1) Hayashi S., Yakugaku Zasshi, 123, 163-171 (2003).

2. 2) Suzuki C., Takahashi T., Kawai S., Kimura S., Kishimoto T., Okamoto K., Sawada M., Jpn. J. Drug Inform., 6, 196-201 (2004).

3. 3) Chounan K., Takashiro H., Nagasawa Y., Tanno M., Muraoka K., Matsuura M., Tosa T., Chounan M., Sasaki K., Takahashi Y., Suzuki H., Hashimoto J., Therapeutic Research, 24, 97-104 (2003).

4. 4) Samizo K., Kawabe E., Hinotsu S., Sato T., Kageyama S., Hamada C., Ohashi Y., Kubota K., Drug Safety, 25, 811-821 (2002).

5. 5) KS DEM Report, Kuraya-Sanseido Inc., 2002.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Event Monitoring and Evaluation by Community Pharmacists in Japan: A Pilot Study on Fenofibrate and Pemafibrate;Current Drug Safety;2022-11

2. Survey on Compliance and Adverse Events for Patients Taking Bisphosphonates and Raloxifene (Chiba Prefecture DEM);Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2008

3. Current State of Community Pharmacy in Japan: Practice, Research, and Future Opportunities or Challenges;Annals of Pharmacotherapy;2006-11